Paolo Pucci
Director/Board Member at WEST PHARMACEUTICAL SERVICES, INC.
Net worth: 4 M $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Philip Astley-Sparke | M | 51 | 9 years | |
| Bill Lundberg | M | 60 | 5 years | |
| Robert Coffin | M | 58 | 9 years | |
| Kapil Dhingra | M | 64 | 12 years | |
| Peter Silverman | M | 46 | 7 years | |
| Sushil Patel | M | 52 | 3 years | |
| Bernard Birkett | M | 55 | 6 years | |
| Eric Green | M | 55 | 9 years | |
| Gregory Perry | M | 63 | 8 years | |
| Mark Iwicki | M | 57 | 9 years | |
| Sushant Kumar | M | - |
Tarus Therapeutics, Inc.
 Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | - |
| Dieter Weinand | M | 63 | 6 years | |
| Anand Mehra | M | 48 | 9 years | |
| Christy Oliger | F | 54 | 3 years | |
| Robert Glassman | M | 62 |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | 3 years |
| Andrew Schwendenman | M | 47 | 4 years | |
| Silji Abraham | M | 52 | 6 years | |
| Kimberly MacKay | F | 58 | 4 years | |
| Victor Sandor | M | 57 | 5 years | |
| Len Kanavy | M | 62 | 6 years | |
| Cindy Reiss-Clark | F | 50 | - | |
| Sherri L. Spear | F | - | - | |
| Andrew Muratore | M | - | 3 years | |
| Deborah Baron | F | 55 | 3 years | |
| Deborah Keller | F | 61 | 7 years | |
| Molly Joseph | F | 50 | 3 years | |
| David Epstein | M | 62 |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | 4 years |
| Colin Love | M | 65 | 9 years | |
| Douglas Michels | M | 66 | 13 years | |
| William Feehery | M | 54 | 12 years | |
| Robert Friel | M | 68 | 4 years | |
| Myla Lai-Goldman | M | 66 | 10 years | |
| Joseph Slattery | M | 59 | 7 years | |
| Mark Buthman | M | 63 | 13 years | |
| Thomas Hofmann | M | 72 | 17 years | |
| Veleka Peeples-Dyer | F | 52 | 1 years | |
| Peter Molloy | M | 52 |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | - |
| Stephen Lockhart | M | 65 | 2 years | |
| Hyam Levitsky | M | 66 | 6 years | |
| Cecilia Anna Wilhelmina Geuijen | M | 56 | 3 years | |
| Christopher Sarchi | M | 55 | 1 years | |
| Konstantinos Xynos | M | 57 | 2 years | |
| Michele Polinsky | M | - | - | |
| Robert Segura | M | - | 3 years | |
| Donald A. McMillan | M | 65 | 27 years | |
| Ernesto Wasserman | M | - | 8 years | |
| Ashley Pereira | M | - | 3 years | |
| Shannon Campbell | F | - | 2 years | |
| Chris Ryan | M | - | - | |
| Alexander Berthold Hendrik Bakker | M | 57 | 14 years | |
| Kathleen Farren | F | - | - | |
| Paul Achleitner | M | 67 | 22 years | |
| Andrew Joe | M | 58 | 4 years | |
| Harry Shuman | M | - | - | |
| Emily Hill | F | 44 | 1 years | |
| Maxine Gowen | M | 66 | 3 years | |
| Liu Hui | M | 51 | 9 years | |
| Arleen Goldenberg | F | - | - | |
| Quintin Lai | M | 57 | 8 years | |
| Annette Favorite | F | 59 | 9 years | |
| C. Nicholson | M | 68 |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | 4 years |
| John de Kruif | M | 60 | 17 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Andrew Ashe | M | 57 | 13 years | |
| George Migausky | M | 69 | 8 years | |
| Jean Franchi | F | 57 | 4 years | |
| Gustav Christensen | M | 76 | 9 years | |
| Robert A. Uger | M | 53 | 8 years | |
| James Parsons | M | 58 | 10 years | |
| David J. McLachlan | M | 86 | 17 years | |
| Henry E. Blair | M | 80 | 27 years | |
| Robert L. Kirkman | M | 75 | 8 years | |
| Ivana Magovcevic-Liebisch | M | 55 | 12 years | |
| Jan Skvarka | M | 57 | 2 years | |
| Patrick Zenner | M | 77 | 20 years | |
| Penka Petrova | M | 56 | 8 years | |
| Ulrich Hauck | M | 60 | 12 years | |
| Joseph Saluri | M | 57 | 7 years | |
| Thomas Hoffmann | M | 53 | 5 years | |
| Willy Beumann | M | 68 | - | |
| Johannes M. Dietsch | M | 62 | 16 years | |
| Bernd Metzner | M | 53 | 4 years | |
| Paul Walker | M | 49 | 1 years | |
| Frank Morich | M | 69 | 20 years | |
| Thomas Lenox Kempner | M | 96 | 21 years | |
| Otello Stampacchia | M | 55 | 7 years | |
| Klaus Sturany | M | 77 | - | |
| Paula Johnson | M | 64 | 16 years | |
| Paul Edick | M | 67 | 7 years | |
| Helmut Gunter Wilhelm Panke | M | 77 | - | |
| Michael A. Anderson | M | 68 | 24 years | |
| David Montecalvo | M | 58 | 6 years | |
| Henry Lewis | M | 98 | 17 years | |
| John Weiland | M | 68 | 12 years | |
| Tanya Lewis | F | 53 | 4 years | |
| Klaus-Christian Kleinfeld | M | 65 | 9 years | |
| Mary Gray | M | 71 | 12 years | |
| William Federici | M | 64 | 15 years | |
| Chad Johnson | M | 45 | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 35 | 35.71% |
| Switzerland | 26 | 26.53% |
| Netherlands | 19 | 19.39% |
| Germany | 10 | 10.20% |
| Canada | 8 | 8.16% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Paolo Pucci
- Personal Network